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Post-Transcriptional Regulation of Glutathione Peroxidase Gene Expression by
Selenium in the HL-60 Human Myeloid Cell Line
By Sunil Chada, Constance Whitney, and Peter E. Newburger
We have used a cloned eDNA for the major human seleno-
protein. glutathione peroxidase (GPx). to assess the mode
of regulation of human GPx gene (GPX-1 ) expression by
selenium. When the HL-60 human myeloid cell line is grown
in a selenium-deficient medium. GPx enzymatic activity
decreases 30-fold compared with selenium-replete cells.
Upon return to a medium containing selenium in the form of
selenite. GPx activity in the cells starts to increase within
48 hours and reaches maximal (selenium-replete) levels at
7 days. Steady-state immunoreactive protein levels corre-
G LUTATHIONE peroxidase (GPx; EC 1.1 1.1.9) is the
most extensively characterized mammalian selenopro-
tein.’3 The enzyme catalyzes the degradation of peroxides
and hydroperoxides to the corresponding alcohol, using
reduced glutathione as a specific hydrogen donor4’5
GPx
H2O2 + 2GSH -‘GSSG + 2H2O.
GPx serves as an important element of the cellular antioxi-
dant defense system by detoxifying peroxides and hydroper-
oxides that would otherwise damage cell membranes and
DNA.”6’7
The enzyme is a homotetramer, with each subunit contain-
ing one atom of selenium.8 Selenium resides in the protein in
a catalytically active selenocysteine residue at amino acid
47,9 The presence of selenocysteine in the active site raises
the important question of how this unusual moiety is incorpo-
rated into GPx. The two major possibilities are post-transla-
tional addition of selenium into a common amino acid or
direct cotranslational incorporation of selenocysteine.
Immunologic studies have failed to find any evidence for a
GPx precursor protein or apoenzyme.’#{176}” Cycloheximide and
puromycin have been shown to inhibit the incorporation of
radiolabeled selenium into GPx in isolated perfused rat
liver.’2 Further studies have suggested that rat liver contains
a species of tRNA that is specific for selenocysteine and that
the aminoacylated tRNA is more active in an in vitro protein
synthesis system than selenite, selenocysteine, or the deacyl-
ated tRNA.’3 Isotope dilution studies have indicated that
free selenocysteine is not an intermediate in the labeling of
GPx by [755e]-selenite.’2 Together, these data suggest, but do
not directly demonstrate, a translational mechanism for
selenocysteine incorporation into GPx. Sequence analysis of
the murine glutathione peroxidase gene has revealed the
selenocysteine residue to be encoded by a thymine-guanine-
adenine (TGA) “termination” codon.’4 An identical codon,
and overall similar sequences, have recently been reported
for the human GPx (GPXJ) gene in clones isolated from
human liver cDNA,’5 kidney cDNA,’6 and genomic’7
libraries.
Using oligonucleotides directed against the bovine amino
acid sequence, we have also isolated cDNA clones corre-
sponding to the human GPx mRNA.’8 The present study
used the cloned GPx cDNA to examine the regulation of the
human GPXJ gene in response to selenium depletion and
late with enzymatic activity. Cycloheximide inhibits the rise
in GPx activity that accompanies selenium replenishment.
indicating that protein synthesis is required for the
increase. However. GPx mRNA levels and the rate of
transcription of the human GPx gene change very little and
thus appear to be independent of the selenium supply.
Thus the human GPx gene appears to be regulated post-
transcriptionally. probably cotranslationally. in response to
selenium availability.
@1989 by Grune & Stratton, Inc.
repletion, using the HL-60 human myeloid leukemia cell
line’9 as an in vitro model system. This cell line can be
cultured in defined medium with and without sodium selenite
supplementation,#{176} thus allowing selenium-dependent regu-
lation of GPx activity in a homogeneous cell population free
of the effects of whole organism nutrition and metabolism.
MATERIALS AND METHODS
Cells. HL-60 cells (originally obtained from Dr R. Gallo’9) were
maintained in RPMI 1640 medium, supplemented with either
insulin, transferrin, and selenium (ITS; ITS premix, Collaborative
Research, Inc. Lexington, MA) containing insulin (5 pg/mL),
transferrin (5 pg/mL) and selenium as sodium selenite (5 ng/mL);
or insulin and transferrin (IT) only.#{176}
In order to assess whether selenium deprivation caused severe
generalized biological consequences, selenium-replete cells (cultured
for 30 days in ITS medium) and selenium-deficient cells (day 20 in
IT medium) were examined for their ability to differentiate morpho-
logically and functionally. Table 1 shows cell morphology, assessed
by differential counting of Wright-Giemsa-stained cytocentrifuge
preparations of HL-60 cells cultured for 3 weeks in ITS or IT
medium and then treated with 80 mmol/L dimethylformamide
(DMF) to induce granulocytic differentiation.2’ Selenium-deficient
and selenium-replete cells developed equally well into the expected
pattern of distribution into progressively more mature myeloid cell
types. Cells grown in IT and ITS also exhibited similar levels of
functional differentiation as assayed by reduction of nitroblue
tetrazolium dye, used as a measure of respiratory burst function
(Table 2). When ITS, IT, or serum-supplemented cells were treated
with phorbol myristate acetate (l0’ mol/L) to induce macrophagic
differentiation,23 they also differentiated similarly, as assayed by
morphology and adherence (data not shown).
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Table 1 . Effect of Selenium on Morphologic Differentiation of
HL-60 Cells
Cells
Granulocytic Differentiat ion Stage
Promyelo Myelo Meta Band PMN
Day 0
IT
ITS
83
87
9 2
9 4
1
0
0
0
Day 2
IT
ITS
49
51
50 1
36 7
0
4
0
2
Day 4
IT
ITS
5
9
71 20
50 30
4
7
0
5
Day 6
IT
ITS
2
1
41 36
35 41
16
24
5
9
HL-60 cells were grown in selenium-replete (ITS) or -deficient (IT)
medium as indicated. Granulocytic differentiation was induced by the
addition of dimethylformamide (DMF) for the times indicated. and the
percentages of differentiated cells assayed morphologically.
Abbreviations: Promyelo, promyelocyte; Myelo, myelocyte; Meta.
metamyelocyte; Band, band neutrophil; PMN. polymorphonuclear leuko-
cyte.
GPx activity. GPx enzymatic activity was monitored using an
adaptation of the coupled peroxidase-reductase method of Beutler.24
Cells were adjusted to 2 x 107/mL in Dulbecco’s phosphate-
buffered saline (PBS) pH 7.4. Both sample and reference cuvettes
contained 106 cells, 0.05% Triton X-l00, 0.2 mmol/L reduced
nicotinamide-adenosine dinucleotide phosphate (NADPH), 2
mmol/L reduced glutathione (GSH), and I U/mL glutathione
reductase. The oxidation of NADPH upon addition of t-butyl
hydroperoxide to the sample cuvette was followed spectrophoto-
metrically at 340 nm.#{176}
Protein separation and detection (Western blotting). Postnu-
clear supernatant fractions from 3 x 106 cells, pretreated with 1
mmol/L diisopropyl fluorophosphate, were prepared as described,25
electrophoresed under reducing conditions on a I 0% sodium dodecyl
sulfate (SDS)-polyacrylamide gel, transferred to nitrocellulose by
standard procedures,26 detected with polyclonal anti-GPx antiserum,
and stained with a goat-anti-rabbit alkaline-phosphatase-coupled
second antibody.
cDNA clones. Human GPx cDNA’8 or its restriction fragments
(digested according to the endonuclease supplier’s instructions) were
Table 2. Functional Differentiation of HL-60 Cells Grown in
Selenium-Replete. Selenium-Deficient. or Fetal Calf
Serum-Containing Medium
NBT ReduCtiOn
Cells Medium 1% Positive)
HL-60 ITS 87
HL-60 IT 89
HL-60 FCS 88
Granulocytes - 98
HL-60 cells were cultured as indicated in RPMI 1 640 medium
containing ITS, IT, or 10% fetal calf serum (FCS) and harvested after 6
days of further incubation in the same medium containing 60 mmol/L
DMF. Granulocytes were isolated from human peripheral blood and
superoxide-generating capacity was determined as the percentage of
cells capable of NBT dye reduction, as described in Materials and
Methods.
gel purified, then cleared ofcontaminating agarose and salt by glass
beads (GENE-CLEAN; Bio 101, Inc. La iolla, CA) and ethanol
precipitation. When necessary, the cDNA was radiolabeled to a
specific activity ofO.5 to 2 x lO cpm/zg using random oligonucleo-
tide primers.27 Other cDNA clones included human tubulin (pro-
vided by Dr P. Dobner), heavy chain of phagocyte NADPH oxidase
b-cytochrome,29 phosphoglycerate kinase#{176}(provided by Dr S.H.
Orkin, The Children’s Hospital, Boston, MA), heavy and light
chains of ferritin3’ (provided by Dr H. Munro, Tufts University,
Boston, MA), and chicken $-actin32 (provided by Dr R. Singer,
University of Massachusetts Medical School, Worcester).
RNA preparation and analysis. Whole-cell RNA was extracted
using the guanidine-HCI method33 and polyadenylated RNA iso-
lated by passage over an oligo-dT cellulose column using standard
methods.M Whole cell or polyadenylated RNA was quantitated
spectrophotometrically, denatured, electrophoresed in a 1 .2% aga-
rose-formaldehyde gel, and then transferred to nitrocellulose or
nylon filters by standard methods. Slot blots from similarly
prepared RNA were performed using a Schleicher & Schuell
Minifold II apparatus according to the instructions of the manufac-
turer (Keene, NH). Procedures for prehybridization, hybridization,
filter washes, and filter stripping were performed as described by
Gatti et al.35 Control RNA from the cellular slime mold Dictyoste-
hum discoideum was provided by Dr Alan iacobson.
Nuclear runon assay for transcription rates. Nuclear runons
were performed with minor modifications of the method developed
for HL-60 cells by Linial et al.36 HL-60 cells were harvested, washed
once in cold PBS and once in reticulocyte standard buffer (10
mmol/L Tris, pH 7.4; 10 mmol/L NaCI; 3 mmol/L MgC12), and
then lysed with 0.5% NP-40 in reticulocyte standard buffer. Nuclei
were collected by centrifugation at 50 x g. washed twice in
reticulocyte standard buffer, and resuspended in nuclear freezing
buffer (40% glycerol; 50 mmol/L Tris, pH 8.3; 5 mmol/L MgCl2;
0.1 mmol/L EDTA) before immediate use or freezing at - 70#{176}C.At
the time of the assay, the nuclear suspensions receive additions of 20
tL of 32P-UTP (3,000 Ci/mmol/L; 10 Ci/L) and 60 zL of runon
buffer (25 mmol/L Tris, pH 8.0; 12.5 mmol/L MgCI2; 750 mmol/L
KCI: I .25 mmol/L each of adenosine triphosphate [ATPJ, guano-
sine triphosphate [GTPJ, and cytodine triphosphate [CTP]; 1 izmol/
L uridine triphosphate [UTP]; 100 g creatine phosphokinase;
I mmol/L dithiothreitol; and 20 mmol/L phosphocreatine). After
incubation for 30 minutes at 26#{176}C,the reaction was stopped by
addition of DNase I and CaC12. Newly synthesized RNA was then
extracted, precipitated, and finally resuspended in hybridization
buffer. Trichloroacetic acid-precipitable cpm were determined and
equal counts for each sample within an experiment, usually 3 to 20 x
106 cpm, were then used for hybridizations. Specific sequences
synthesized in the reaction were detected by hybridization to nonla-
beled cDNA probes that were denatured by boiling and applied to
filters in a slot-blot apparatus. The filters were baked, prehybridized,
and hybridized with the labeled, newly synthesized, RNA for 36 to
48 hours at 65#{176}C.The filters were washed, dried, and exposed to
roentgenographic film for autoradiography.
Probes for the nuclear runoffs included a 350 bp fragment
containing the 5’ portion of the GPx cDNA, a 600 bp clone from the
central region of the GPx cDNA, and a I 50 bp restriction fragment
representing the 3’UT region of the GPx cDNA; M13 phage (not
shown) and pBR322 plasmid served as negative controls for nonspe-
cific hybridization.
Densitometry of Northern blots and nuclear runoffs were per-
formed on a Helena Laboratories QuickScan (Beaumont, TX) and
areas under the curves determined by the weight of cut-out chart
paper. For Northern blots, results for the GPx probe were normal-
ized to the relative densities of the /3-actin or phosphoglycerate
kinase signals.
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Effect of selenium on GPx activity and protein. We
have used the HL-60 cell line’9 as a model system to study
the regulation of expression of the human GPx gene by
selenium. This cell line may be maintained in a defined
medium consisting of RPMI 1640 plus insulin and trans-
ferrin, with or without supplemental selenium (IT and ITS
media, respectively).20
To examine the effects of selenium depletion, HL-60 cells
grown in ITS medium were pelleted and resuspended in IT.
Alternatively, cells cultured in IT medium for 2 to 4 weeks to
deplete them of selenium were selenium replenished by
transfer to ITS medium. Aliquots were removed at various
timepoints during these treatments. As shown in Fig I, cells
from selenium-replete medium (ITS point at day 1) con-
tamed substantial amounts of GPx enzymatic activity
(slightly less than 250 nmol/L NADPH oxidized/min/lO’
cells). When these cells were transferred to selenium-
deficient medium (ITS -bIT curve), a time-dependent
decrease in enzymatic activity occurred. After 20 days in
selenium-deficient medium, the cells contained only 4% of
the GPx activity of the initial selenium-replete cells. When
selenium-deficient cells were returned to selenium-replete
medium (IT - ITS), enzymatic activity increased 25-fold to
the level of fully replete cells over approximately seven days.
Thus, the exogenous selenium supply appears to control the
enzymatic activity of GPx in these cells. The rate of change
of enzyme activity with selenium replenishment is slower
than might be expected if selenium were incorporated into a
pre-existing stable apoenzyme.
Total cellular proteins isolated from selenium-replete and
selenium-deficient HL-60 cells were analyzed using a poly-
clonal antibody raised against human erythrocyte GPx.’#{176}
The Western blot shown in Fig 2 indicates that selenium
depletion causes a rapid decrease in cellular GPx immunore-
active protein, with negligible levels being observed after
seven days in IT medium. When these cells were returned to
selenium-replete (ITS) medium (ie, day 20 in IT was day 0
0
C
E
0,
It)
a
z
0
E
C
Fig 1 . GPx activity of HL-60 cells during selenium depletion and
replenishment. Selenium-replete cells (ITS) were transferred to
selenium-deficient medium (ITS - IT) and GPx activity assayed at
the indicated number of days tborein (abscissa). Selenium-deficient
cells (IT) were transferred to selenium-replete medium (IT -‘ ITS)
and GPx activity similarly assayed. GPx activity was measured
spectrophotometrically as the oxidation of NADPH. as described in
Materials and Methods.
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RESULTS in ITS), GPx protein was detectable after 2 days, and was
substantially higher after 30 days of selenium replenishment.
These changes in immunoreactive GPx protein roughly cor-
relate with GPx enzymatic activity, and thus further support
the model of selenium regulation of GPx synthesis, as
opposed to insertion into a pre-existing apoenzyme. The
findings also confirm our previous studies using the same
antibody in a radioimmunoassay.’#{176}
Inhibition of protein synthesis by cycloheximide (CYX)
was used to investigate whether the increase in GPx activity
with selenium is due to de novo protein synthesis in
selenium-replenished cells. As illustrated in Fig 3, selenium-
deficient cells (equilibrated in IT medium) showed a 4.6-fold
increase in GPx activity 24 hours after transfer to ITS
medium. However, when the ITS also contained CYX 50
jg/mL (ITS + CYX), the rise in activity was nearly abol-
ished, with only a 1 .6-fold rise evident. CYX treatment of
selenium replete cells (ITS + CYX in the lower panel of Fig
3) caused a decrease in GPx activity similar in magnitude to
that observed when the replete cells were transferred to
selenium-deficient medium (IT; lower panel). The combina-
tion of CYX and selenium depletion (IT + CYX) did not
diminish GPx activity significantly more than either treat-
ment alone. These results indicate that the increase in
activity observed with selenium replenishment requires pro-
tein synthesis.
CYX treatment of ITS cells produced a decrease in
activity similar to that observed when selenium was removed
from replenished cells. This finding suggests a rapid inhibi-
tion of synthesis of GPx protein and is consistent with the
model of a specific translational block in the absence of
selenium.
Effect of selenium on GPx gene expression. We next
examined GPX mRNA levels in selenium-replete cells
(grown in ITS medium for 30 days) or selenium-deficient
cells (grown in IT medium for 20 days). Figure 4 shows an
autoradiograph of a slot blot from such an experiment. The
indicated amounts of total cellular RNA from ITS cells and
IT cells were probed with the cDNA for GPx. RNA from the
cellular slime mold D discoideum served as a negative
control. Densitometric scans of this blot and Northern blots
from similar experiments (not shown) demonstrated a range
of only 1.2- to 2.3-fold more GPX mRNA in selenium-
replete than in selenium-deficient cells, relative to the levels
of constitutively expressed control transcripts (f3-actin and
phosphoglycerate kinase). On the slot blot, the ratios were
similar at each RNA amount loaded (range, 1.36 to 1.99).
Thus, selenium depletion caused a decrease in steady-state
levels of GPx mRNA, but the change was not nearly
sufficient to explain the 25-fold difference in enzyme activity
0 1 2 3 5 7 20 and content.
Days In order to test whether selenium depletion affects GPx
gene expression at the level of transcription, nuclear runon
experiments were performed to examine transcription rates
of the GPx gene in selenium replete (ITS) or deficient (IT)
cells. Radiolabeled runoff RNA from ITS and IT cells was
hybridized with filters bearing slots with immobilized cDNA
fragments representing the 5’ end, the middle, and the 3’ end
of the GPx transcription unit. The results are shown in Fig 5
ITS
300
200
100
. . . .
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DAY:O 1 5 7
Se-Deficient IT U
(IT) ITS
ITS+CYX 
Se-Replete ITS
(ITS) ITS + CYX
IT
IT +CYX
Fig 3. Effect of CYX on GPx activity during selenium replenish-
ment. Selenium-deficient or -replete HI-SO cells were pelleted and
resuspended in either IT or ITS medium. with CYX 50 tg/mL in the
indicated groups. GPx enzyme activity. shown as the horizontal
bars. was measured spectrophotometrically 24 hours later.
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28kd-”
18kd-’
ITS-”IT
0 2 5
IT-ITS
Fig 2. Immunoreactive GPx protein in HL-60 cells during selenium depletion and replenishment. analyzed by Western blotting.
Selenium-replete cells were transferred to selenium-deficient medium (IT) and protein extracted at days 1 . 5. 7. and 20 (as indicated) of
selenium depletion. The resultant selenium-deficient cells were transferred to selenium-replete medium (ITS. day 20 in IT becomes day 0
in ITS) and protein extracted at days 2. 5. and 30 (as indicated) of selenium replenishment. Western blot analysis using a polyclonal
anti-GPx antibody was performed as described in Materials and Methods; the size markers on the left indicate the positions of 28-Kd and
1 8-Kd molecular weight standards.
The signals obtained from all three GPx probes were only
slightly higher in the replete relative to the deficient cell
nuclei. Similar ITS to IT labeling ratios were observed for
the GPx probe at the 5’ and 3’ ends of the mRNA, indicating
that there was no interruption of transcription37 between the
two exons in selenium-deficient cells. The other genes studied
in this experiment (/3-actin, phagocyte cytochrome b heavy
chain [X-CGD], and ferritin heavy and light chains) dis-
played a similar, slight difference in transcription rates in
selenium-deficient and -replete cell nuclei. The observed
transcription rates parallel the steady-state levels of the
transcripts, indicating a small but general transcriptional
enhancement in the selenium-replete state (or inhibition in
selenium deficiency). Overall, these results support the infer-
ence that the major degree of regulation of GPx expression
by selenium is not mediated at the level of gene tran-
scription.
DISCUSSION
We have used the human HL-60 myeloid cell line as a
model system to study the relationship between selenium
supply and the expression of the human gene for GPx, an
unusual mammalian selenoprotein incorporating selenocys-
teine in its active site.9 GPx enzymatic activity was approxi-
GPx ACTIVITY
RESUSPENSION (nmol NADPH oxidized/mini 10’ cells)
CELLS MEDIUM 0 100 200 300
I- I I I
mately 30-fold higher in selenium-replete than -deficient
cells. When replete cells were deprived of selenium, enzy-
matic activity decreased rapidly, reaching selenium-deficient
baseline levels after approximately 10 days. Replenishment
of deficient cells with selenium led to a marked increase in
activity (to 25% of selenium-replete) within 24 hours and full
activity after 7 days. Steady-state levels of GPx protein
correlated with enzymatic activity. CYX studies showed that
the increase in GPx activity in response to selenium required
protein synthesis, and that the decrease in activity upon
selenium deprivation may be mimicked by blocking protein
synthesis. However, steady-state levels of GPx mRNA and
the rate of transcription of the GPx gene were essentially
independent of the selenium supply. These studies show that
the availability of selenium controls human GPx activity and
that regulation is exerted at a post-transcriptional level.
The relationship between selenium supply and GPx
enzyme activity in vivo has received extensive investigation
both experimentally in animals38 and clinically in humans.39’#{176}
ITS IT pg RNA loaded
2
5
HL-60
10
20
20 Dictyostelium
Fig 4. GPx mRNA expression in selenium-replete (ITS) and
-deficient (IT) HI-SO cells. The cells were cultured for 3 weeks in
the indicated medium before harvesting for extraction of total
cellular RNA and slot blot analysis as described in Materials and
Methods. Total cellular RNA from the cellular slime mold D discoi-
deum served as a negative control. Each slot contained the amount
of RNA indicated to the right.
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5,
GPx
3,
pBR
X-CGD
TUBULIN
-ACTI N
FERRITI Nf H
[L
ITS IT
Fig 5. Transcription of GPx mRNA in nuclei from selenium-
replete and -deficient HI-SO cells. The autoradiograph shows the
amount of RNA transcribed in vitro by nuclei from cells grown in ITS
or IT medium. The labels on the left indicate the cDNA probes used
to identify the newly synthesized mRNA: GPx probes. including full
length eDNA (center) and restriction fragments from its 5’ and 3’
ends as indicated; pBR (plasmid negative control); the phagocyte
cytochrome b heavy chain (X-CGD); tubulin; $-actin; and ferritin
heavy (H) and light (1) chains.
However, the effect of selenium deprivation on GPx gene
expression in vivo has been studied only recently by several
groups reporting differing results. Saedi et al,4’ using a murine
GPx cDNA, and Yoshimura et al,42 using a rat GPx cDNA,
found on Northern blot analysis that liver from selenium-
deficient rats contained much lower GPx mRNA levels than
liver from selenium-replete rats. However, Reddy et al,43 using
a rat GPx cDNA in similar experiments, found virtually equal
levels of GPx transcripts in selenium-deficient and -replete
liver extracts. Our results, in a defined in vitro system, are
more consistent with the latter findings, which are also
suggestive of post-transcriptional regulation. However, vary-
ing control mechanisms may operate in studies involving
different species, cell lineages, and experimental designs.
A likely mechanism of post-transcriptional regulation
would be cotranslational insertion of selenocysteine into GPx.
Recently, analyses of the murine’4 and human’5”6”8 GPx
cDNA sequences have demonstrated the very unusual occur-
rence of the TGA “terminator” codon at the position encoding
selenocysteine. The carbon backbone of selenocysteine in GPx
has recently been shown to be derived from serine” rather
than cysteine. Taken together with Tappel’s previous demon-
stration of a selenocysteyl-tRNA,’3 these findings suggest the
following cotranslational model for insertion of selenocysteine
into GPx: a uracil-guanine-adenine (UGA)-recognizing
tRNA is charged with serine, which is then enzymatically
altered to generate a selenocysteyl-tRNA, which in turn
incorporates selenocysteine directly at the UGA codon occur-
ring in the appropriate codon context. Such a cotranslational
mechanism for selenocysteine incorporation at a UGA codon
has recently been directly demonstrated in the synthesis of
formate dehydrogenase in Escherichia co/i.45
Possible candidate tRNAs for this process are the opal
(UGA) suppressor tRNA species that have been character-
ized by Hatfield et al in mammalian, avian, and Xenopus
tissues; they are the only known naturally occurring suppres-
sor tRNAs in higher eukaryotes. They are aminoacylated by
seryl-tRNA synthetase and then phosphorylated to form
phosphoseryl-tRNA. Their unique features and extreme con-
servation suggest that they may be used in specific biochemi-
cal processes requiring suppression of terminator codons
within specific sequence contexts. The insertion of selenocys-
teine into GPx may represent one such condition, in that the
modified amino acid is derived from serine and the sequence
context of the UGA is unusual and perhaps conducive to
selective secondary structure.’8
Thus, regulation could proceed by control of the translation
process at the mRNA UGA triplet that can function either as
the codon for selenocysteine or as a terminator. Selenium
incorporated into a selenocysteyl-tRNA could allow transla-
tional read-through whereas, in the absence of selenium, the
selenocysteine tRNA could remain unacylated and the UGA
codon would then function in its more usual terminator
capacity. Alternatively, translation in the absence of selenium
could proceed at a normal or somewhat reduced rate, but with
misincorporation of a different amino acid (eg, phosphoser-
ine). In that case, the resultant inactive protein would also
have to be very unstable in order to escape detection by the
polyclonal antisera used in our western blots (Fig 2) and
radioimmunoassays)#{176} The Western blot also failed to detect
any truncated GPx polypeptide, the translation product that
would be expected if termination were taking place at the
UGA codon in selenium-deficient cells. However, such a short
(46-amino acid) peptide may be unstable in the cytoplasmic
milieu and rapidly degraded.
Alternatively, a post-translational mechanism of control
would provide a consistent, but less attractive, model for the
present studies. Direct insertion of selenium into the com-
pleted 22 Kd GPx polypeptide has been proposed.47’ The
latter study suggested that selenocysteine was generated by a
modification reaction between the side chain of cysteine in the
polypeptide and a precursor selenium compound. However,
such post-translational insertion of selenium into a stable
apoenzyme is unlikely in view of the relatively slow kinetics
and dependence on protein synthesis for rise in GPx activity
after selenium replenishment (Figs I and 3), as well as the
absence of immunoreactive GPx protein on Western blotting
(Fig 2). The existence of a labile apoenzyme cannot be ruled
out. However, it would have to be either very unstable in the
absence of selenium or not be recognized by the anti-GPx
antibody used in this study. The latter possibility is unlikely
since the antibody, generated against purified human erythro-
cyte GPx, is polyclonal and recognizes both native and
SDS-denatured GPx protein. However, selenium could be
required to stabilize a labile GPx apoenzyme in the manner of
metal-binding proteins, such as ferritin,49 that may be pro-
tected against degradation by the prosthetic group.
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Finally, more complex mechanisms could account for the
post-transcriptional regulation of human GPx expression by
selenium. For example, further analogies may be drawn to the
regulation of ferritin synthesis by iron, mediated both by
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